---
title: Enable Biotech Ltd vs Porton Advanced
slug_a: enablebiotech
slug_b: porton-advanced
site: cdmo
review_signal_gate: closed
canonical_path: /compare/enablebiotech/porton-advanced
---

# Enable Biotech Ltd vs Porton Advanced

Side-by-side profile data from each company listing on this directory.

## Enable Biotech Ltd

- Profile: [/companies/enablebiotech](/companies/enablebiotech)

Enable Biotech Ltd — Enable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024.

Services: 4. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (4).

### Services

- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)

## Porton Advanced

- Profile: [/companies/porton-advanced](/companies/porton-advanced)

Porton Advanced — End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe.

Services: 14. Modalities: 4. Indications: 0. Locations: 18. Certifications: 0. The strongest documented coverage currently appears in locations (18).

### Services

- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Cell-Free